{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.04","value":"3.01"}]}],"title":"Conventional dosimetry"},{"categories":[{"measurements":[{"groupId":"OG000","spread":"3.1","value":"3.41"}]}],"title":"Patient-specific dosimetry"}],"denomUnitsSelected":"tumor","denoms":[{"counts":[{"groupId":"OG000","value":"7"}],"units":"Participants"},{"counts":[{"groupId":"OG000","value":"7"}],"units":"tumor"}],"description":"tumor absorbed dose (Gy)","dispersionType":"Standard Deviation","groups":[{"description":"Tumor absorbed dose calculations determined using both conventional dosimetry and 3D-RD patient-specific dosimetry software.","id":"OG000","title":"Conventional & Patient-specific Dosimetry"}],"paramType":"MEAN","reportingStatus":"POSTED","timeFrame":"up to 4 years","title":"Tumor Absorbed Dose","type":"PRIMARY","typeUnitsAnalyzed":"tumor","unitOfMeasure":"Gy"}